Compare ZVRA & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVRA | SNDL |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.9M | 432.6M |
| IPO Year | 2015 | 2019 |
| Metric | ZVRA | SNDL |
|---|---|---|
| Price | $8.10 | $2.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $21.71 | $5.00 |
| AVG Volume (30 Days) | 1.1M | ★ 3.5M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | $84,388,000.00 | ★ $683,170,243.00 |
| Revenue This Year | $333.25 | $5.48 |
| Revenue Next Year | $43.70 | $3.10 |
| P/E Ratio | $15.11 | ★ N/A |
| Revenue Growth | ★ 244.60 | 4.43 |
| 52 Week Low | $6.19 | $1.15 |
| 52 Week High | $13.16 | $2.89 |
| Indicator | ZVRA | SNDL |
|---|---|---|
| Relative Strength Index (RSI) | 36.09 | 58.66 |
| Support Level | $8.05 | $1.87 |
| Resistance Level | $8.58 | $1.75 |
| Average True Range (ATR) | 0.34 | 0.13 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 6.63 | 71.54 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.